Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Goodwill & Intangibles (2019 - 2025)

Historic Goodwill & Intangibles for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to $134.9 million.

  • Pharming's Goodwill & Intangibles rose 10109.4% to $134.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.9 million, marking a year-over-year increase of 10109.4%. This contributed to the annual value of $143.4 million for FY2024, which is 10126.85% up from last year.
  • According to the latest figures from Q3 2025, Pharming's Goodwill & Intangibles is $134.9 million, which was up 10109.4% from $232.3 million recorded in Q2 2025.
  • In the past 5 years, Pharming's Goodwill & Intangibles registered a high of $232.3 million during Q2 2025, and its lowest value of $70123.0 during Q3 2022.
  • Its 5-year average for Goodwill & Intangibles is $82.0 million, with a median of $75.1 million in 2022.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first tumbled by 9992.25% in 2022, then skyrocketed by 9950925.8% in 2023.
  • Over the past 5 years, Pharming's Goodwill & Intangibles (Quarter) stood at $84616.1 in 2021, then skyrocketed by 88678.6% to $75.1 million in 2022, then dropped by 5.13% to $71.3 million in 2023, then soared by 101.27% to $143.4 million in 2024, then decreased by 5.93% to $134.9 million in 2025.
  • Its last three reported values are $134.9 million in Q3 2025, $232.3 million for Q2 2025, and $138.9 million during Q1 2025.